 Safety efficacy thrombolytic therapy superior vena experience Cleveland Clinic thrombolytic therapy superior vena cava SVC syndrome Sixteen patients central venous catheters urokinase streptokinase urokinase U/kg bolus U/kg/h streptokinase bolus U/h venograms Overall percent patients complete clot lysis relief symptoms Thrombolytic therapy effective percent patients urokinase percent patients streptokinase central venous catheter percent patients percent patients catheter present thrombolytic therapy equal days symptom onset percent patients successful thrombolytic therapy days symptom onset percent patients successful Symptoms catheter patients thrombolytic therapy effective Factors success use urokinase streptokinase presence central venous catheter duration symptoms equal days